Plague Modification in 2012: Cutting/Scoring Balloons and atherectomy

Size: px
Start display at page:

Download "Plague Modification in 2012: Cutting/Scoring Balloons and atherectomy"

Transcription

1 Plague Modification in 2012: Cutting/Scoring Balloons and atherectomy Coronary Therapies Mark Reisman,MD Swedish Heart and Vascular Institute Seattle,Wa

2 Disclosure I, Mark Reisman, MD SAB- Boston Scientific Honorarium from Boston Scientific and, Advisory Board: Biostar Ventures

3 Heavily calcified RCA

4 Final result 1.5 f/b 2.0mm Burr f/b stenting And high pressure Post dilation The patient did develop Slow flow after the 1.5 Burr.waited.ST segments resolved

5 Role in Drug Eluting Stenting Managing moderate to severe calcification Advancement of stents (balloons) in rigid calcified lesions??? Strut symmetry Ostial Lesions (RCA) LMCA 70% stretch? With debulking

6 Catheter Components Forward Pressure defines depth of diamonds digging Into vessel drive shaft diamond coated burr 1.25 mm mm (0.25 mm increments) sheath 4.3 french O.D. guide wire Continuous movement keeps device from becoming Warm especially in angled/tortuous vessels

7 Console rotational speed display (tachometer) procedure timer reset button turbine pressure gauge (delivered to advancer) event timer turbine pressure control knob (adjusts RPM) advancer fiber optic tachometer connector Dynaglide connector power switch advancer turbine power lamp (pneumatic) connector

8 Rotablator System Mechanism of Action Orthogonal Displacement Of friction Differential Cutting

9 Mechanism of Action Orthogonal Displacement of friction frictional forces are minimized in the longitudinal plane permits the burr to negotiate tortuous segments of vessel without much resistance STILL tortuous segments can lead to decreases in RPM s and that needs to be differentiated from lesions (may require using smaller burr size)

10 Differential Cutting Differential Cutting Elastic tissue Inelastic tissue Results in preferential cutting of inelastic substrate Is functional at low and high speeds Reisman, M.D, Guide to Rotational Atherectomy. Physicians Press, Birmingham, MI 1997 The burr will cut (ablate) inelastic tissue (calcium, fibrous material) while sparing elastic tissue Therefore burr may be somewhat ineffective in softer lesions AND In cases of guide wire bias, where the wire is not centered (majority of cases) the wire may press on the lesion and convert elastic tissue to inelastic tissue, thus cutting will take place, i.e. tortuous vessels, severely angulated vessels

11 Lesion Modification, Not Calcium Removal Concentric plaque with superficial circumferential calcium Make one thin segment in circumferential calc Good dissection before stent

12 GuideWire Bias and Ablation Proximal Distal

13 Minimizing Particle size Controlling Particle size Gentle advancement Minimal decelerations Start proximal to the lesion Don t allow the device to jump forward Rotablator Micro Particles s Red Blood Cells 5 Micron Bead t

14 Temp. (C) Manufactured for Heat reduction Sources of Heat RotaLink TM Effluent Peak Temperatures Advancement of burr/tortuous anatomy Between vessel wall and burr Between guidewire and burr Long run times (excess of 45 seconds Time (min.) Temp w/saline Temp. w/rotaglide Reduction in Vasospasm and?? Platelet Reduction

15 The game plan Preprocedure Guide catheter selection Guide wire selection Burr selection Platforming speed Advancing the burr

16 Preprocedure Issues Good Hydration Knowing segmental and global LV function (including valvular pathology) Anticoagulation-prefer heparin if risk of perforation greater than standard Pressors available/atropine/ temp. wire in cases of RCA/LMCA/ or usage of larger burrs 2.38mm etc

17 Guide Catheter Issues/TPM Support usually not an issue, coaxial guide is the most important Larger guides may be helpful for better visualization We no longer use side hole guides for Rotablator, only if anatomy dictates Guide orientation will dictate orientation of guidewire which sets the platform for the entire case Six french can accommodate up to a 1.75mm burr TPM when to use..it depends

18 Guidewire Issues-makes a difference in ablation Two available- (floppy and extrasupport) Extrasupport Delivery Directional cutting Floppy Tortuosity Workhorse

19 Selecting a burr Keep it Small, in almost all cases Rotational atherectomy is being used for lesion modification Traditionally start with a 1.5mm or 1.75mm, 1.25mm in CTOs when PCI fails to dilate lesion, in the absence of a dissection would start with a 1.75mm or 2.0mm burr If severe decelerations (especially on bends) downsize the burr.

20 Operating the device Bring the burr to the lesion, then slightly retract to take the compression out of the system Inject contrast to confirm egress of dye Begin treatment Often the speed will be lower than the outside the body 150k test, that is okay Advance burr gently with forward and backward motion Take occasional injections to see progress Minimize decelerations (listening should be enough) Run time seconds

21 Operating the device II Once treatment completed should be no resistance and no drop in rpms Remove the device immediately, anything that is subsequently required will not be helped by further rotational atherectomy Assess for flow (I pay more attention to the downstream vessel then the lesion site) Assess for spasm (general vessel diameter) Assess patients hemodynamics, chronotropic reponse to the burr and chest pain

22 Adverse events Slow flow/no Reflow Vasodilators Low pressure undersized balloon in distal vessel (switch guidewire out usually done with rotational atherectomy at this point Time Spasm Vasodilators Low pressure PCI distally Hypotension Pressors sooner than later/iabp if secondary to slow flow things may get worse quickly

23 Why all the concern STRATAS TRIAL STRATAS tested an aggressive vs. Routine strategy for debulking. Restenosis high in the both arms Avs.R(57% vs58%),. No or slow reflow was 15.7% in the aggressive arm (burr to artery ratio >7) and 7.7% in the routine arm (burr to artery ratio <.7) (p=.008). Independent predictors were decelerations of >5000 rpm for more than 5 seconds. **This study was performed prior to the recommendation of reduced rpms (150,000). The lower rpms put less torque in the system and thus for any given reduction release less energy essentially, less heat. Whitlow PL, Bass TA, Kipperman RM, Sharaf BL, Ho KK, Cutlip DE, et al. Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS). Am J Cardiol 2001;87(6):

24 Results-The SPORT TRIAL PTCA + Stent N = 318 Rota + Stent N = 312 Angiographic Success 100% (318) 100 % (312) NS P value Clinical Success 84.5 % (267) 80.3% (244) NS (angio success w/ no MACE) MLD post procedure (mm) P=0.42

25 Adverse effects II If Slow/no reflow, severe chest pain Recommend no further Rotational atherectomy, check compliance of lesion with balloon and if okay proceed to stenting, if still undilatable need to measure risks of further dilation If severe bradycardia and stepping up to larger burr TPM Prepare the patient to cough, stop device with slowing of heart rate, (remember always pull back device to platform segment

26 Lesion specific management Calcification Bifurcations Ostial lesions ISR Tortuosity

27 Calcification USE The Rotablator-will shorten procedure, and Simplify procedure If unsure whether to upsize burr, attempt PCI up to atms, if lesion expands go to stenting Advance gently, these lesions usually respond very well m/p higher rate of slow flow, and more predominant in RCA

28 Bifurcations Cannot double wire Care on severe diagonal/om branches, highest risk for perforations (1.25mm burrs indicated here) Do not sit on these highly angulated lesions, guidewire bias often forces eccentric cut. Proximal to bifurcation if there is a lesion can change cutting orientation by moving wire from parent to branch vessel therefore get greater cutting from a single burr

29 Rotational atherectomy of Both Limbs

30 Instent Restenosis With DES results done much less frequently Still helps in diffuse ISR Very low risk cases and terrific cases to get feel for device Great care if going through stent struts for any reason, can get caught on opposite side if burr watermelon seeds through

31 Long Lesions Do NOT have to pass entire lesion in one run Remember gentle not slow, some long lesions can be done relatively quickly Take injections during run to get locator Do NOT stop burr mid way in lesion always bring back to platform segment Second third runs will have lower platform speed, not to worry (anything above about 120K for burrs mm is okay) Assess with nitro, often will have spasm with longer lesions Overburdening the distal bed is rare, slow flow and no reflow most probably secondary to platelet activation, these are good cases for glycoprotein IIB/IIIA inhibitors

32 Long Lesion

33 Tortuosity Try to pick most coaxial guide, especially in lesions like ostial circumflex Undersize burr Significantly if lots of pseudolesions and wrinkling of the vessel Be clear where lesion is since deformation my make things very difficult Be sure to start the burr in platform segment with adequate clearance

34 CTO No antegrade flow use 1.25mm burr Abrupt deceleration m/p subintimal Vasospasm may hinder antegrade flow in the presence of significant retrograde colaterals. Results Tsuchikane et. al demonstrated reduction in restenosis with stenting (52vs.29%p=.02) Tsuchikane E, Otsuji S, Awata N, Azuma J, Nakaoka Y, Uesugi H, et al. Impact of pre-stent plaque debulking for chronic coronary total occlusions on restenosis reduction. J Invasive Cardiol 2001;13(8): Dietz U, Erbel R, Rupprecht HJ, Weidmann S, Meyer J. High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions. Br Heart J 1993;70(4):

35 Rotational atherectomy and. Angiomax-. The use of Bivalirudin in patients undergoing RA was studied retrospectively in a cohort of 253 patients. no difference in incidence of myonecrosis between the two groups, but the heparin treated group was significantly more likely to be treated with GP IIb/IIIa (91% vs. 25%; p = 0.001). Statins-reduced incidence of myonecrosis (21% vs. 7%) Nicorandil-lower incidence of slow and no reflow (9% vs. 2%) compared to verapamil Plavix- The recent use of antiplatelet drugs such as Plavix has not been studied as to the effect on slow/no reflow in the context of RA Gurm HS, Rajagopal V, Bhatt DL, Ellis SG, Lincoff AM. The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy. J Invasive Cardiol 2007;19(5): Gurm HS, Breitbart Y, Vivekanathan D, Yen MH, Fathi R, Ziada KM, et al. Preprocedural statin use is associated with a reduced hazard of postprocedural myonecrosis in patients undergoing rotational atherectomy--a propensity-adjusted analysis. Am Heart J 2006;151(5):1031 e1-6. Matsuo H, Watanabe S, Watanabe T, Warita S, Kojima T, Hirose T, et al. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and

36 But you need to choose carefully

37 Unprotected LMCA

38 LMCA II

39 LMCA III

40 Undilatable lesion

41 Undilatable lesion-ii

42 Undilatable lesion-iii

43 Undilatable lesion IV

44 Angles.

45 Angles II

46 Cutting Balloons Atherotomes affixed to a balloon. Expand radically as balloon is inflated to score arterial plaque.

47 Cutting Balloons Advantages - controlled dissection - non-compliant balloon material Disadvantages - cost - profile - limited lengths, limited use - stiff, bulky catheter

48 Minimizing Vessel Trauma Cutting Balloon Device Plaque Modification Atherotome Wire The atherotomes severs the elastic and fibrotic continuity of the vessel wall allowing plaque compression with less vessel trauma 1 Atherotome 3-5 x Sharper than Surgical Blade 1 Bonan, J Invasiv Cardiol, 1999; 11: 230

49 Minimizing Vessel Trauma Cutting Balloon Device Alteration via Plaque Modification Microsurgical incision Dissection flap Cutting Balloon Device Linear Incision Conventional Balloon Traumatic Dilatation Photo Courtesy of Prof. K Mizuno

50 AngioSculpt Semi-compliant balloon with an external nitinol shape memory helical scoring edge 2 component system Rapid exchange or or OTW delivery Laser cut nitinol spiral cage

51 AngioSculpt Mechanical Forces Edges lock in ~15-25x force 1x force

52 OCT of RCA Lesions Post-AngioSculpt De Novo (E) and ISR (F) Lesions Post-AngioSculpt OCT of De Novo Lesion Post-AngioSculpt demonstrating scoring (white arrowheads) OCT of ISR Lesion Post- AngioSculpt demonstrating scoring (white arrowheads) Takano et al, Int J Cardiol 2008, doi: /j.ijcard

53 Quantitative Angio Analysis Acute Gain (mm) ± 0.2 Group I (Direct Stent) p < ± 0.4 Group II (Pre-dilatation with semi-compliant balloon) 1.2 ± 0.4 group III (AngioSculpt) Costa JR et al; Amer J Cardiol 2007;100:812-17

54 AGILITY: Baseline Lesion Characteristics Bifurcation Angle (distal): 48.94±15.35 degrees Range degrees 9.7% of lesion bifurcation angles > 70 degrees Medina Class (N=93) 1, 1, 1 68 (73.1) 0, 1, 0 2 (2.1) 1, 0, 1 1 (1.1) 1, 0, 0 1 (1.1) 0, 1, 1 16 (17.2) 0, 0, 1 1 (1.1) 1, 1, 0 4 (4.3) 0, 0, 0 0 (0) 92.5% of lesions were Medina Class (x, x, 1) by core lab analysis

55 AGILITY Trial Final Results AGILITY OPC P-Value Primary Endpoint Procedural Success 91.4% 88.2% * Secondary Endpoints Side-Branch Bailout Stenting 10.9% 27% <0.001** Final Kissing Balloon 16.3% 50% <0.001** * Non-inferiority ** superiority Angiographic success: 93.5%

56 Diamondback 360 Crowns CLASSIC CROWN Up to 1.5 x orbit Crown sizes: 1.25, 1.5, 1.75, 2.0 SOLID CROWN Up to 1.75 x orbit Crown sizes: 1.5, 1.75, 2.0, 2.25

57 Unique Mechanism of Action Differential Sanding Diamond-coating crown differentially sands noncompliant plaque; elastic tissue flexes away Minimal damage to arterial wall Maximal luminal gain achieved with increased centrifugal force Centrifugal Force CF=mass*rotational speed 2 radius of the orbit Effective plaque removal Crown flexes away from compliant tissue

58 Conclusion What is complex for PCI is often easy for rotational atherectomy-i.e. Left main calcified lesions/ostial lesions As we do MORE will NEED more rotational atherectomy Earlier you decide in complex lesions to use it the faster the case the better the outcome, almost universally Get your feet wet in ISR cases if have not used it in a while Remember no evidence in restenosis, so use it for lesion modification for optimal stenting

59 conclusion Essential device, and must have comfort with using it. Reserved for the most complex cases Often what is complex for PCI is straightforward when using rotational atherectomy Get the experience.

60 Which of the following is incorrect regarding Rotational atherecomy A-differential cutting favors ablation of inelastic plaque B-lower speed is associated with decreased platelet activation C-double wire techniques is advisable to protect side branches D-rotational atherectomy is contraindicated in ostial lesions

61 Which of the following is incorrect regarding Rotational atherecomy A-differential cutting favors ablation of inelastic plaque B-lower speed is associated with decreased platelet activation C-double wire techniques is advisable to protect side branches D-rotational atherectomy is contraindicated in ostial lesions Answer C

62 The effectiveness of Rotational atherectomy is best seen in A-undilatable lesions B acute MI patients C to reduce restenosis D large vessels E saphenous vein grafts

63 The effectiveness of Rotational atherectomy is best seen in A-undilatable lesions B acute MI patients C to reduce restenosis D large vessels E saphenous vein grafts Answer A

64 Regarding guidewire bias which of the following is incorrect A-Can be favorable and unfavorable B may be source of perforation in angulated lesions C Can be reduced with the use of a more flexible guidewire D Can result in more efficient debulking E in cases where it is seen larger burrs should be employed

65 Regarding guidewire bias which of the following is incorrect A-Can be favorable and unfavorable B may be source of perforation in angulated lesions C Can be reduced with the use of a more flexible guidewire D Can result in more efficient debulking E in cases where it is seen larger burrs should be employed Answer E

66 Which of the following are true regarding using lower rotational speeds during treatment with the Rotablator: A-the operator has greater sensitivity when advances since the device has lower power and thus lower torque B-lower speeds do not achieve the critical speed to produce microcavitation c- heat generation for any drop in rpm at the lower speed is less then seen with higher rpms. D-stalls or rapid decelerations with the rotablator may be seen with rapid advancement of the device when in atherosclerotic plaque E- all of the above

67 Which of the following are true regarding using lower rotational speeds during treatment with the Rotablator: A-the operator has greater sensitivity when advances since the device has lower power and thus lower torque B-lower speeds do not achieve the critical speed to produce microcavitation c- heat generation for any drop in rpm at the lower speed is less then seen with higher rpms. D-stalls or rapid decelerations with the rotablator may be seen with rapid advancement of the device when in atherosclerotic plaque E- all of the above Answer E- all of the above. Using rotational speeds of approximately 150,000 makes the ablation or sanding process much more sensitive to advancement through stenoses. Heat and microcavitation have been shown to have a negative impact on arterial vessels and thus lower speeds may mitigate and reduce those effects.

68 Which of the following regarding dynaglide is false: a-it is the method of using rotational reduction in friction to remove the device from the body b-since it is a lower speed selection it should be used to ablate lesions c- it works on a servocontrol, thus when the speed is reduced for whatever reason more power is put into the system. d- it is activated with the footpedal e all of the above are true.

69 Which of the following regarding dynaglide is false: a-it is the method of using rotational reduction in friction to remove the device from the body b-since it is a lower speed selection it should be used to ablate lesions c- it works on a servocontrol, thus when the speed is reduced for whatever reason more power is put into the system. d- it is activated with the footpedal e all of the above are true. Answer B- It should never be used to advance through a lesion since it is on a servocontrol mechanism, thus the operator would loss completely the feedback of decelerations when treating the lesion.

70 Rotational atherectomy increases the late loss in Drug eluting stents and in stented Calcified lesions 1-true 2-false

71 Rotational atherectomy increases the late loss in Drug eluting stents and in stented Calcified lesions 1-true 2-false False-results have shown comparable results for rotational atherecomy and stenting (DES or BMS ) and stenting alone.

Evolu'on of Balloon Angioplasty From POBA to newer technologies NCVH May 26, 2015

Evolu'on of Balloon Angioplasty From POBA to newer technologies NCVH May 26, 2015 Evolu'on of Balloon Angioplasty From POBA to newer technologies NCVH May 26, 2015 Cezar Staniloae, MD Heart and Vascular Ins7tute New York University Medical Center Overview 1. Physics of balloon angioplasty

More information

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Ostial LAD: Single stent approach is the best Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Chair, Interventional Cardiology Sanatorio San Lucas Instituto Alexander Fleming Buenos

More information

A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III

A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III Gilles Montalescot, MD, PhD Pitié-Salpêtrière Hospital, Paris, France

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

Coronary Bifurcation Treatment: Update from the European Bifurcation Club. Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy)

Coronary Bifurcation Treatment: Update from the European Bifurcation Club. Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy) Coronary Bifurcation Treatment: Update from the European Bifurcation Club Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy) Disclosure Statement of Financial Interest Within the past 12 months, I

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Coronary & Peripheral Guidewires. Roby Rakhit

Coronary & Peripheral Guidewires. Roby Rakhit Coronary & Peripheral Guidewires Roby Rakhit 1 st wire for PTCA introduced by Simpson & Roberts in 1982 Choice of Guidewire Anatomy Vessel angulation, tortuosity, bifurcation, CTO Lesion Characteristics

More information

Majestic Trial 12 Month Results

Majestic Trial 12 Month Results Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.

More information

Choice of guiding catheters and guidewires

Choice of guiding catheters and guidewires Choice of guiding catheters and guidewires Dr. Ahmad Elsayed Yousef, MD Lecturer of Cardiology, Ain Shams University Werner Frossmann-1929 1 X-ray for angioraphy (1950-1970) Cine frame from the first selective

More information

INTERVENTION IN OSTIAL CORONARY LESIONS:

INTERVENTION IN OSTIAL CORONARY LESIONS: INTERVENTION IN OSTIAL CORONARY LESIONS: Antony (92), le 18 septembre 2013 JEAN MARC PERNES Hopital Privé Antony FRANCE Perfection of Precise Ostial Stent Placement Ostial lesions, including aorta ostial

More information

PATIENT INFORMATION BOOKLET

PATIENT INFORMATION BOOKLET PATIENT INFORMATION BOOKLET Wingspan Stent System with Gateway PTA Balloon Catheter TABLE OF CONTENTS Definitions... 2 What is the Purpose of This Booklet?... 3 What is an Intracranial Lesion?... 3 Who

More information

The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program

The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program Jean Fajadet, MD, FESC Clinique Pasteur - Toulouse - France Disclosure statement Nothing to disclose Dedicated Delivery

More information

Rotational Atherectomy for the Treatment of In-Stent Restenosis

Rotational Atherectomy for the Treatment of In-Stent Restenosis Home SVCC Area: English - Español - Português Rotational Atherectomy for the Treatment of In-Stent Restenosis Steven L. Goldberg, MD Cardiac Catheterization Laboratory, University of Washington Medical

More information

Deflectable & Steerable Catheter Handbook

Deflectable & Steerable Catheter Handbook Deflectable & Steerable Catheter Handbook Terminology Guide & Design Options www.cregannatactx.com California Minnesota Ohio Ireland Singapore Terminology Steering v s Deflection Steerability This refers

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Coronary Stents. What is a Coronary Artery stent?

Coronary Stents. What is a Coronary Artery stent? What is a Coronary Artery stent? Coronary Stents A coronary stent is stainless tube with slots. It is mounted on a balloon catheter in a "crimped" or collapsed state. When the balloon of is inflated, the

More information

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:

More information

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases T. Masood,T. Sagheer,D. Jan,N. Qamar,A.M.A. Faruqui ( National Institute of Cardiovascular Diseases (NICVD), Karachi.

More information

The Pantera Lux Paclitaxel DEB Device Description and Clinical Studies. Christoph Hehrlein, University Clinic Freiburg i.br.

The Pantera Lux Paclitaxel DEB Device Description and Clinical Studies. Christoph Hehrlein, University Clinic Freiburg i.br. The Pantera Lux Paclitaxel DEB Device Description and Clinical Studies Christoph Hehrlein, University Clinic Freiburg i.br. Germany Disclosure Statement of Financial Interest Within the past 12 months,

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Drug-Eluting Balloons Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Potential conflicts of interest Speaker s name: Klaus Bonaventura

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application Coronary Stent System for Drug Application Yukon Choice DES + new catheter polymer-free DES Translumina - The polymer-free DES solution www.translumina.de A First Class Stent The YUKON Choice DES+ is the

More information

Orsiro Hybrid Drug Eluting Stent Industry's first hybrid DES

Orsiro Hybrid Drug Eluting Stent Industry's first hybrid DES Vascular Intervention Drug Eluting Stents Orsiro Orsiro Hybrid Drug Eluting Stent Industry's first hybrid DES Orsiro An ideal combination of passive and active components The Orsiro Hybrid Drug Eluting

More information

Cardiac Catheterization

Cardiac Catheterization Page 1 Cardiac Catheterization What Other Terms Are Used To Describe Cardiac Catheterization? Heart Cath (catheter) Angiogram What Is Cardiac Catheterization? This procedure is nonsurgical and is performed

More information

StentViz Enhanced Stent Visualization

StentViz Enhanced Stent Visualization GE Healthcare StentViz Enhanced Stent Visualization Dr. Morice, Dr. Lefèvre, Dr. Hovasse, Dr. Chevalier, Dr. Louvard Institut Cardiovasculaire Paris Sud, Massy, France Assessing the deployment of stents

More information

GRAFTMASTER RX Coronary Stent Graft System PPL2082232 (2/1/13)

GRAFTMASTER RX Coronary Stent Graft System PPL2082232 (2/1/13) GRAFTMASTER RX Coronary Stent Graft System PPL2082232 (2/1/13) Graphical Symbols for Medical Device Labeling Manufacturer Sterilized using ethylene oxide Catalogue number Batch code French size Outer diameter

More information

Intracoronary Stenting and. Robert A. Byrne, Julinda Mehilli, Salvatore Cassese, Franz-Josef Neumann, Susanne Pinieck, Tomohisa Tada,

Intracoronary Stenting and. Robert A. Byrne, Julinda Mehilli, Salvatore Cassese, Franz-Josef Neumann, Susanne Pinieck, Tomohisa Tada, Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis in Limus- Eluting Stents Intracoronary Stenting

More information

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up Hellenic J Cardiol 45: 379-383, 2004 Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up PETROS S. DARDAS, DIMITRIS

More information

An Informative Guide for Heart Catheterization Patients & Families

An Informative Guide for Heart Catheterization Patients & Families An Informative Guide for Heart Catheterization Patients & Families What is a Cardiac Cath? Cardiac catheterization is a procedure used to diagnose and treat patients who have various forms of heart disease.

More information

Wingspan Stent System with Gateway PTA Balloon Catheter

Wingspan Stent System with Gateway PTA Balloon Catheter Wingspan System with Gateway PTA Balloon Catheter Directions for Use AUS Australian Sponsor Address Boston Scientific (Australia) Pty Ltd PO Box 332 BOTANY NSW 1455 Australia Free Phone 1800 676 133 Free

More information

Ischemia and Infarction

Ischemia and Infarction Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to

More information

TAXUS Express 2. Paclitaxel-Eluting Coronary Stent System. Patient Information Guide

TAXUS Express 2. Paclitaxel-Eluting Coronary Stent System. Patient Information Guide TAXUS Express 2 Paclitaxel-Eluting Coronary Stent System Patient Information Guide 1 Table of Contents Coronary Artery Disease...2 Who Is at Risk?...3 Diagnosis of Coronary Artery Disease...3 Treatment

More information

LEADERS: 5-Year Follow-up

LEADERS: 5-Year Follow-up LEADERS: -Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable Polymer : Final Report of the LEADERS

More information

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland CORONARY ARTERY BYPASS GRAFTS First performed

More information

One wire. Many possibilities.

One wire. Many possibilities. One wire. Many possibilities. OptoWire One. The one wire you need for pre- and post-procedure FFR and device delivery. Medical Experience an entirely new level of productivity with OptoWire One Reliable

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

2014 A N N U A L R E P O R T

2014 A N N U A L R E P O R T 2 014 A N N U A L R E P O R T 2014: A Year of Transformation Spectranetics delivers innovative, minimally invasive cardiovascular technologies that are transforming patient care in more than 65 countries

More information

Angioplasty and Stent Education Guide

Angioplasty and Stent Education Guide Angioplasty and Stent Education Guide Table of Contents Treating coronary artery disease...2 What is coronary artery disease...3 Coronary artery disease treatment options...4 What are coronary artery

More information

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014 Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

California Health and Safety Code, Section 1256.01

California Health and Safety Code, Section 1256.01 California Health and Safety Code, Section 1256.01 1256.01. (a) The Elective Percutaneous Coronary Intervention (PCI) Pilot Program is hereby established in the department. The purpose of the pilot program

More information

Popliteal artery: to stent or not to stent?

Popliteal artery: to stent or not to stent? Popliteal artery: to stent or not to stent? Karl-Ludwig Schulte Vascular Center Berlin Ev. Hospital Königin Elisabeth St. Gertrauden Hospital University Hospital Charité, CC11 Humboldt-University Berlin

More information

Hemostasis Solutions Boston Scientific is committed to improving patient care in the management of gastrointestinal bleeding.

Hemostasis Solutions Boston Scientific is committed to improving patient care in the management of gastrointestinal bleeding. Hemostasis Solutions Boston Scientific is committed to improving patient care in the management of gastrointestinal bleeding. Through innovation and continuous educational support, we offer a wide range

More information

Passive Range of Motion Exercises

Passive Range of Motion Exercises Exercise and ALS The physical or occupational therapist will make recommendations for exercise based upon each patient s specific needs and abilities. Strengthening exercises are not generally recommended

More information

Clinical Programs. Medtronic Coronary Stent Systems. driver BMS

Clinical Programs. Medtronic Coronary Stent Systems. driver BMS Clinical Programs Medtronic Coronary Stent Systems Endeavor DES driver BMS July 2010 Contents Overview of Clinical Programs... 2 Drug-Eluting Stents ENDEAVOR I*... 4 ENDEAVOR II*... 6 ENDEAVOR II Continued

More information

Clinical Training for Visage 7 Cardiac. Visage 7

Clinical Training for Visage 7 Cardiac. Visage 7 Clinical Training for Visage 7 Cardiac Visage 7 Overview Example Usage 3 Cardiac Workflow Examples 4 Remove Chest Wall 5 Edit Chest Wall Removal 6 Object Display Popup 7 Selecting Optimal Phase 8 Thick

More information

Ultrasound in Vascular Surgery. Torbjørn Dahl

Ultrasound in Vascular Surgery. Torbjørn Dahl Ultrasound in Vascular Surgery Torbjørn Dahl 1 The field of vascular surgery Veins dilatation and obstruction (varicose veins and valve dysfunction) Arteries dilatation and narrowing (aneurysms and atherosclerosis)

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON

OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON - Baseline preliminary results - Takashi Akasaka, MD, PhD, FESC Wakayama Medical University,

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

Review of Intracoronary Radiation for In-Stent Restenosis

Review of Intracoronary Radiation for In-Stent Restenosis Review of Intracoronary Radiation for In-Stent Restenosis Robert Lew, MBBS, FRACP, Andrew Ajani, MD, Ron Waksman, MD, FACC Vascular Brachytherapy using beta and gamma radiation is the standard care for

More information

Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options. A Guide for Patients

Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options. A Guide for Patients Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options A Guide for Patients Coronary Artery Disease If you or a member of your family has been diagnosed with coronary artery

More information

Overview of Newer Stent Devices for Aneurysm Treatment

Overview of Newer Stent Devices for Aneurysm Treatment Overview of Newer Stent Devices for Aneurysm Treatment Randall C. Edgell, M.D. Associate Professor Vascular and Interventional Neurology Saint Louis University Disclosure Outcome adjudication for THERAPY,

More information

The left internal mammary artery (LIMA) is the

The left internal mammary artery (LIMA) is the Case Report 925 Direct Stenting of a Transradial Left Internal Mammary Artery Graft Wei-Chin Hung, MD; Bih-Fang Guo, MD, PhD; Chiung-Jen Wu, MD; Chien-Jen Chen, MD; Chih-Yuan Fang, MD Taking the transfemoral

More information

USE OF SIMULATION TO IMPROVE CARDIOVASCULAR STENT DEVELOPMENT

USE OF SIMULATION TO IMPROVE CARDIOVASCULAR STENT DEVELOPMENT USE OF SIMULATION TO IMPROVE CARDIOVASCULAR STENT DEVELOPMENT V. Astier, S. Bidal, V. Garitey, F. Mouret Abstract : A stent is a wire metal mesh tube placed into an artery or blood vessel to hold the structure

More information

on behalf of the AUGMENT-HF Investigators

on behalf of the AUGMENT-HF Investigators One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas

More information

Abdominal Aortic Aneurysm (AAA) General Information. Patient information Leaflet

Abdominal Aortic Aneurysm (AAA) General Information. Patient information Leaflet Abdominal Aortic Aneurysm (AAA) General Information Patient information Leaflet 1 st July 2016 WHAT IS THE AORTA? The aorta is the largest artery (blood vessel) in the body. It carries blood from the heart

More information

Subclavian Steal Syndrome By Marta Thorup

Subclavian Steal Syndrome By Marta Thorup Subclavian Steal Syndrome By Marta Thorup Definition Subclavian steal syndrome (SSS), is a constellation of signs and symptoms that arise from retrograde flow of blood in the vertebral artery, due to proximal

More information

TAXUS Express2 Paclitaxel-Eluting Coronary Stent System TAXUS Liberté Paclitaxel-Eluting Coronary Stent System. A Patient s Guide

TAXUS Express2 Paclitaxel-Eluting Coronary Stent System TAXUS Liberté Paclitaxel-Eluting Coronary Stent System. A Patient s Guide TAXUS Express2 Paclitaxel-Eluting Coronary Stent System TAXUS Liberté Paclitaxel-Eluting Coronary Stent System A Patient s Guide Table of Contents Coronary Artery Disease... 2 Who Is at Risk?... 3 Diagnosis

More information

Imaging of Thoracic Endovascular Stent-Grafts

Imaging of Thoracic Endovascular Stent-Grafts Imaging of Thoracic Endovascular Stent-Grafts Tariq Hameed, M.D. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana Disclosures: No relevant financial

More information

GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA - A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES -

GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA - A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES - EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Cosmetics and Medical Devices MEDDEV 2.7.1 Appendix 1 December 2008 GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA

More information

WallFlex Biliary RX Stent. Fully, Partially and Uncovered Self-Expanding Metal Stents

WallFlex Biliary RX Stent. Fully, Partially and Uncovered Self-Expanding Metal Stents WallFlex Biliary RX Stent Fully, Partially and Uncovered Self-Expanding Metal Stents WallFlex Biliary RX Stent Fully, Partially and Uncovered Self-Expanding Metal Stents The WallFlex Biliary RX Stent is

More information

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital

More information

Thyroid Surgery at Massachusetts General Hospital Frequently Asked Questions

Thyroid Surgery at Massachusetts General Hospital Frequently Asked Questions Thyroid Surgery at Massachusetts General Hospital Frequently Asked Questions Q: What is the thyroid gland? A: The thyroid is a butterfly-shaped gland located in the front of the neck. It is one of the

More information

Non-surgical treatment of severe varicose veins

Non-surgical treatment of severe varicose veins Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in

More information

Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page)

Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) The Kidney and the Renal Arteries... 1 Renal Artery Disease... 2 Diagnosis of Renal.Artery Disease...

More information

TURQUOISE PTCA BALLOON DILATATION CATHETER

TURQUOISE PTCA BALLOON DILATATION CATHETER TURQUOISE PTCA BALLOON DILATATION CATHETER TURQUOISE PTCA BallOOn Dilatation CATheter The right BAlance TO meet the clinical need TURQUOISE PTCA s advanced catheter technology offers the right balance

More information

12 Lead ECGs: Ischemia, Injury & Infarction Part 2

12 Lead ECGs: Ischemia, Injury & Infarction Part 2 12 Lead ECGs: Ischemia, Injury & Infarction Part 2 McHenry Western Lake County EMS Localization: Left Coronary Artery Right Coronary Artery Right Ventricle Septal Wall Anterior Descending Artery Left Main

More information

Venous Reflux Disease and Current Treatments VN20-87-A 01/06

Venous Reflux Disease and Current Treatments VN20-87-A 01/06 Venous Reflux Disease and Current Treatments Leg Vein Anatomy Your legs are made up of a network of veins and vessels that carry blood back to the heart The venous system is comprised of: Deep veins Veins

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Study the following diagrams of the States of Matter. Label the names of the Changes of State between the different states.

Study the following diagrams of the States of Matter. Label the names of the Changes of State between the different states. Describe the strength of attractive forces between particles. Describe the amount of space between particles. Can the particles in this state be compressed? Do the particles in this state have a definite

More information

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES Effective January 1, 2015, there was a change in CPT that affects reporting specific endovascular services provided in the

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

Cardiac Catheterization Lab Procedures

Cardiac Catheterization Lab Procedures UW MEDICINE PATIENT EDUCATION Cardiac Catheterization Lab Procedures This handout describes how cardiac catheterization works. It also explains how to prepare for your procedure and the self-care needed

More information

Supera Peripheral Stent System Instructions for Use

Supera Peripheral Stent System Instructions for Use Supera Peripheral Stent System Instructions for Use Table of Contents 1.0 DEVICE DESCRIPTION 2.0 HOW SUPPLIED 3.0 INDICATIONS 4.0 CONTRAINDICATIONS 5.0 WARNINGS 6.0 PRECAUTIONS 6.1 Stent Delivery System

More information

Coding Updates for 2013: Cardiology

Coding Updates for 2013: Cardiology Coding Updates for 2013: Cardiology Presented by: David Dunn, MD, FACS CIRCC, CPC-H, CCVTC, CCC, CCS, RCC National Coding Standards Sources of information Centers for Medicare and Medicare (CMS) Provider

More information

A Fishy Tale. Observing the Circulatory System of a Goldfish with a Compound Light Microscope

A Fishy Tale. Observing the Circulatory System of a Goldfish with a Compound Light Microscope A Fishy Tale Observing the Circulatory System of a Goldfish with a Compound Light Microscope A Fishy Tale About this Lesson In this lesson, students will explore a computer animation of the human body

More information

The Cardiac Society of Australia and New Zealand

The Cardiac Society of Australia and New Zealand The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

Everolimus Eluting Coronary Stent System. Patient Information Guide

Everolimus Eluting Coronary Stent System. Patient Information Guide Everolimus Eluting Coronary Stent System Patient Information Guide Table of Contents Coronary Artery Disease (CAD)...5 Your Heart...5 What is CAD?...5 What are the Symptoms of CAD?...5 What are the Risk

More information

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 I. Overview of Training in Cardiac Catheterization Cardiac catheterization

More information

AND SYLLABUS FOR INTERVENTIONAL CARDIOLOGY SUBSPECIALITY TRAINING IN EUROPE

AND SYLLABUS FOR INTERVENTIONAL CARDIOLOGY SUBSPECIALITY TRAINING IN EUROPE CURRICULUM AND SYLLABUS FOR INTERVENTIONAL CARDIOLOGY SUBSPECIALITY TRAINING IN EUROPE Document prepared by: Carlo Di Mario, FESC Germano Di Sciascio, FESC Jean-Luc Dubois-Rande,FESC Rolf Michels, FESC

More information

Zimmer Small Fragment Universal Locking System. Surgical Technique

Zimmer Small Fragment Universal Locking System. Surgical Technique Zimmer Small Fragment Universal Locking System Surgical Technique Zimmer Small Fragment Universal Locking System 1 Zimmer Small Fragment Universal Locking System Surgical Technique Table of Contents Introduction

More information

The treatment of peripheral vascular disease has

The treatment of peripheral vascular disease has Covered s in Peripheral Vascular Aneurysms and Emergencies Reviewing current covered stent selection and use through case study and discussion. By Alberto Posabella, MD; Raffaele Rosso, MD, FACS, FRCS;

More information

12276408.3. Instructions for Use Cordis EXOSEAL TM VASCULAR CLOSURE DEVICE

12276408.3. Instructions for Use Cordis EXOSEAL TM VASCULAR CLOSURE DEVICE 12276408.3 Instructions for Use Cordis EXOSEAL TM VASCULAR CLOSURE DEVICE Figure 1: Components of the EXOSEAL TM Vascular Closure Device 1. Handle Assembly 2. Plug Deployment Button 3. Indicator Window

More information

Mechanical Properties of Nitinol Stents and Stent-grafts. Comparison of 6 mm Diameter Devices

Mechanical Properties of Nitinol Stents and Stent-grafts. Comparison of 6 mm Diameter Devices Mechanical Properties of Nitinol Stents and Stent-grafts Comparison of 6 mm Diameter Devices P E R F O R M A N C E b y d e s i g n Purpose The association of target vessel restenosis with stent fractures

More information

Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions

Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions ORIGINAL CONTRBUTION / CLINICAL INVESTIGATION Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions Aram J. Mirza Correspondence: Dr. Aram J.Mirza Interventional

More information

Surgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart

Surgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Surgical Options for Venous Disease Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Chronic Venous Disease Approximately 23% of adults in the US have varicose veins Estimated 22 million women

More information

Right Heart Catheterization from the Arm

Right Heart Catheterization from the Arm Right Heart Catheterization from the Arm Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine 1 Disclosure Statement of Financial Interest Within the

More information

OCT STEMI: OCT guidance during stent implantation

OCT STEMI: OCT guidance during stent implantation OCT STEMI: OCT guidance during stent implantation in primary PCI. A Randomized Multicenter study with 9-month optical coherence tomography follow-up Červinka P 1,2, Kala P 3, Jakl M 2,4, Kaňovský J 3,

More information

NOVOSTE BETA-CATH SYSTEM

NOVOSTE BETA-CATH SYSTEM HOSPITAL INPATIENT AND OUTPATIENT BILLING GUIDE FOR THE NOVOSTE BETA-CATH SYSTEM INTRAVASCULAR BRACHYTHERAPY DEVICE This guide is intended solely for use as a tool to help hospital billing staff resolve

More information